MSD Animal Health Introduces COBACTAN LA 7.5% in Europe
EU - MSD Animal Health (known as Merck Animal Health in the USA and Canada) recently obtained regulatory approval in 21 European countries for COBACTAN® LA 7.5% (cefquinome) - a new-generation, injectable antimicrobial for the treatment of swine respiratory disease (SRD).
30 May 2012
2 minute read
